RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PTCT
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

PTC Therapeutics stock downgraded to Strong Sell Candidate
(Updated on Jul 22, 2024)

Sell candidate since Jun 25, 2024 Loss -6.03% PDF

The PTC Therapeutics stock price gained 1.23% on the last trading day (Monday, 22nd Jul 2024), rising from $32.63 to $33.03. During the last trading day the stock fluctuated 2.06% from a day low at $32.54 to a day high of $33.21. The price has risen in 6 of the last 10 days and is up by 4.1% over the past 2 weeks. Volume fell on the last day by -53 thousand shares and in total, 475 thousand shares were bought and sold for approximately $15.68 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 5.18% during the next 3 months and, with a 90% probability hold a price between $28.63 and $43.68 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PTCT Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The PTC Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $33.32 and $34.45. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, May 20, 2024, and so far it has fallen -17.67%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for PTC Therapeutics stock

PTC Therapeutics finds support from accumulated volume at $32.14 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.670 between high and low, or 2.06%. For the last week, the stock has had daily average volatility of 3.46%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PTCT) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect PTC Therapeutics to open at $32.93, and during the day (based on 14 day Average True Range), to move between $31.43 and $34.63, which gives a possible trading interval of +/-$1.60 (+/-4.83%) up or down from last closing price. If PTC Therapeutics takes out the full calculated possible swing range there will be an estimated 9.66% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $33.29 (0.79%) than the support at $32.14 (2.69%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is PTC Therapeutics stock A Buy?

The PTC Therapeutics stock holds several negative signals and despite the positive trend, we believe PTC Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.078 Strong Sell Candidate Downgraded

Predicted Opening Price for PTC Therapeutics of Tuesday, July 23, 2024

Fair opening price July 23, 2024 Current price
$32.93 ( 0.313%) $33.03

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PTCT

Fibonacci Support & Resistance Levels

Level Price
R3 33.60 1.72%
R2 33.34 0.94%
R1 33.18 0.462%
Price 33.03
S1 32.67 -1.09%
S2 32.51 -1.57%
S3 32.26 -2.34%

Accumulated Volume Support & Resistance Levels

Level Price
R3 40.12 21.47%
R2 36.52 10.57%
R1 33.29 0.787%
Price 33.03
S1 32.14 -2.69%
S2 30.58 -7.42%
S3 28.57 -13.50%

FAQ

What is the symbol for PTC Therapeutics Stock and on which exchange is it traded?
The symbol for PTC Therapeutics is PTCT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell PTC Therapeutics Stock?
The PTC Therapeutics stock holds several negative signals and despite the positive trend, we believe PTC Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy PTC Therapeutics Stock?
PTC Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy PTC Therapeutics Stock.

What's the current price of PTC Therapeutics Stock?
As of the end of day on the Jul 22, 2024, the price of an PTC Therapeutics (PTCT) share was $33.03.

What is the 52-week high and low for PTC Therapeutics Stock?
The 52-week high for PTC Therapeutics Stock is $42.14 and the 52-week low is $17.53.

What is the market capitalization of PTC Therapeutics Stock?
As of the Jul 22, 2024, the market capitalization of PTC Therapeutics is 2.533B.

When is the next earnings date for PTC Therapeutics?
The upcoming earnings date for PTC Therapeutics is Aug 01, 2024.
Click to get the best stock tips daily for free!

About PTC Therapeutics

PTC Therapeutics PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple therapeutic areas, such as rare diseases. The company offer... PTCT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT